Class information for:
Level 1: DIFFUSE PANBRONCHIOLITIS//ROXITHROMYCIN//AZITHROMYCIN

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
11099 942 35.8 79%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
2085 4774 DIFFUSE PANBRONCHIOLITIS//AZITHROMYCIN//ROXITHROMYCIN

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DIFFUSE PANBRONCHIOLITIS Author keyword 124 80% 8% 78
2 ROXITHROMYCIN Author keyword 13 24% 5% 48
3 AZITHROMYCIN Author keyword 11 10% 11% 107
4 MACROLIDES Author keyword 10 10% 10% 96
5 MACROLIDE Author keyword 8 11% 7% 68
6 MACROLIDE ANTIBIOTICS Author keyword 6 18% 3% 31
7 PATHOGENESIS DIS CONTROL Address 5 50% 1% 7
8 DIFFUSE PANBRONCHIOLITIS DPB Author keyword 4 67% 0% 4
9 EM900 Author keyword 4 75% 0% 3
10 SINOBRONCHIAL SYNDROME Author keyword 3 40% 1% 6

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 DIFFUSE PANBRONCHIOLITIS 124 80% 8% 78 Search DIFFUSE+PANBRONCHIOLITIS Search DIFFUSE+PANBRONCHIOLITIS
2 ROXITHROMYCIN 13 24% 5% 48 Search ROXITHROMYCIN Search ROXITHROMYCIN
3 AZITHROMYCIN 11 10% 11% 107 Search AZITHROMYCIN Search AZITHROMYCIN
4 MACROLIDES 10 10% 10% 96 Search MACROLIDES Search MACROLIDES
5 MACROLIDE 8 11% 7% 68 Search MACROLIDE Search MACROLIDE
6 MACROLIDE ANTIBIOTICS 6 18% 3% 31 Search MACROLIDE+ANTIBIOTICS Search MACROLIDE+ANTIBIOTICS
7 DIFFUSE PANBRONCHIOLITIS DPB 4 67% 0% 4 Search DIFFUSE+PANBRONCHIOLITIS+DPB Search DIFFUSE+PANBRONCHIOLITIS+DPB
8 EM900 4 75% 0% 3 Search EM900 Search EM900
9 SINOBRONCHIAL SYNDROME 3 40% 1% 6 Search SINOBRONCHIAL+SYNDROME Search SINOBRONCHIAL+SYNDROME
10 MACROLIDE THERAPY 3 50% 0% 4 Search MACROLIDE+THERAPY Search MACROLIDE+THERAPY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DIFFUSE PANBRONCHIOLITIS 135 53% 19% 179
2 LONG TERM AZITHROMYCIN 35 47% 6% 55
3 LOW DOSE ERYTHROMYCIN 21 50% 3% 30
4 LOW DOSE TROLEANDOMYCIN 19 76% 1% 13
5 IMMUNOMODULATORY MEDICATIONS 19 74% 1% 14
6 ROXITHROMYCIN 13 18% 7% 64
7 STEROID REQUIRING ASTHMA 12 86% 1% 6
8 NEUTROPHILIC AIRWAY INFLAMMATION 12 59% 1% 13
9 METHYLPREDNISOLONE ELIMINATION 11 57% 1% 13
10 14 MEMBERED RING MACROLIDES 8 75% 1% 6

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Immunomodulatory Effects of Macrolide Antibiotics - Part 1: Biological Mechanisms 2011 39 89 76%
Anti-inflammatory effects of macrolides - an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? 2005 167 48 58%
Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications 2010 110 305 61%
Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases 2012 55 253 46%
Azithromycin: Mechanisms of action and their relevance for clinical applications 2014 15 288 37%
Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis 2004 85 56 95%
Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators 2008 94 67 79%
Macrolide antibiotics as immunomodulatory medications: Proposed mechanisms of action 2008 104 128 69%
Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review 2011 30 28 57%
Long-term macrolide therapy in chronic inflammatory airway diseases 2009 60 72 53%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 PATHOGENESIS DIS CONTROL 5 50% 0.7% 7
2 U 479 2 67% 0.2% 2
3 DIPARTIMENTO MALATTIE PARATO P TORACE 1 38% 0.3% 3
4 PROVEL 1 38% 0.3% 3
5 SHANGHAI P DIS 1 50% 0.2% 2
6 UNIT INFLAMMAT IMMUN 1 19% 0.4% 4
7 ABORAT MASS SPE OMETRY INNOVAT 1 50% 0.1% 1
8 ALLOGENE BONE MARROW TRANSPLANT PROGRAM 1 50% 0.1% 1
9 BEIJNG P MED 1 50% 0.1% 1
10 BIOMED ENGN PHYSIOL PHARMACOL 1 50% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000153351 CEFODIZIME//SUBINHIBITORY CONCENTRATIONS//BRODIMOPRIM
2 0.0000131408 AZITHROMYCIN//CLARITHROMYCIN//DIRITHROMYCIN
3 0.0000121927 BRONCHIECTASIS//MIDDLE LOBE SYNDROME//GUANGZHOU P DISAFFILIATED HOSP 1
4 0.0000116454 EQUIPE ACCUEIL EA 3105//ESCHERICHIA COLI WP2UVRA PKM101//DIRECC INVEST ENSENANZA
5 0.0000102677 STEROID DEPENDENT ASTHMA//STEROID SPARING AGENTS//ALLERGY P CARE
6 0.0000090729 BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA//CRYPTOGENIC ORGANIZING PNEUMONIA//ORGANIZING PNEUMONIA
7 0.0000078382 JOURNAL OF CYSTIC FIBROSIS//INHALED TOBRAMYCIN//PULMONARY EXACERBATION
8 0.0000067368 MUC5AC//AIRWAY MUCIN//MUC5B
9 0.0000056379 TILMICOSIN//ACYLIDE//KETOLIDE
10 0.0000056024 PRULIFLOXACIN//ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS//ACUTE EXACERBATION OF CHRONIC BRONCHITIS